FDA Inspection 1263799 - Naseem A. Jaffrani, M.D. - March 13, 2025

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Record Details

This FDA Inspection record concerns Naseem A. Jaffrani, M.D., with an inspection on March 13, 2025, issued by the New Orleans District Office, covering human drugs.

Company: Naseem A. Jaffrani, M.D.
Inspection Date: March 13, 2025
Product Type: Human Drugs
Office: New Orleans District Office

Open in Dashboard

ID · 96752f27-f4ce-4b23-a5a2-f6468691536e

Violation Codes6

21 CFR 312.6021 CFR 312.62(a)21 CFR 312.62(b)21 CFR 312.64(b)21 CFR 312.6621 CFR 50.27(a)

Full citation text and observation details available on the Dashboard.